Pfizer subcontractor allegedly concealed irregularities during vaccine trials – RT en français
| Top stories | Usa news
A former manager of the Ventavia company, which was conducting tests for Pfizer during phase III trials of the Covid-19 vaccine, told the British Medical Journal that she had observed numerous deviations from standards, before being fired.
During phase III of clinical trials on the vaccine against the Covid of Pfizer and BioNTech, a subcontractor of the American pharmaceutical company would have been negligent and falsified data related to the patients, according to an investigation by British Medical Journal (BMJ) released on November 2.
The review is based on the testimony of Brook Jackson, employed for two weeks as regional manager of the Ventavia group, based in Texas. The latter is a “contractual research company”, a subcontracting company specializing in the conduct of clinical trials. Ventavia was employed by Pfizer to conduct trials on 1,000 people, for a total of 44,000 patients tested worldwide during the final trial in fall 2020, prior to vaccine approval.
Brook Jackson explained to the BMJ that he observed – during phase 3 of the trials – falsified data, deviations from double-blind randomized study methods, the use of insufficiently trained employees and delays in reporting adverse reactions. The medical journal specifies that the whistleblower provided the BMJ with “dozens of internal company documents, photos, audio recordings and e-mails”.
Ventavia continued to work with Pfizer on the vaccine for children and pregnant women
After repeatedly informing Ventavia of these issues, Brook Jackson sent an email complaint to the Food and Drug Administration (FDA) in September 2020. Ventavia fired her the same day, on the grounds that she was “not a good recruit”, according to the dismissal letter consulted by the BMJ.
Referring to testimonies from other former employees of Ventavia, the medical journal claims to have documents that would show poor storage of vaccines used for tests, conditions of use of syringes not meeting health standards, and which would prove that almost -all company staff could have access to patient identity data, which contradicts the blind test method.
These irregularities would have worried the board of directors of Pfizer, concerned about possible audits on the part of the Food and drug administration. But despite the alerts on Ventavia, still according to the BMJ, the contractor continued to work with Pfizer, participating in smaller trials to evaluate the vaccine in children, pregnant women, and as a booster dose.
News Today abc News Pfizer subcontractor allegedly concealed irregularities during vaccine trials – RT en français